A new study suggests that suppressing a cellular enzyme long considered protective against fatty liver disease could have unexpected long-term consequences. Scientists have uncovered a troubling tradeoff in the liver. An enzyme called Caspase-2 has attracted attention as a possible…
Continue reading with a subscription
This article is available to subscribers. Subscribe to read it in full, or sign in if you already have an account.